The Biomarker and Cardiac Function in Sepsis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The development and severity of sepsis induced myocardial dysfunction can be monitored from the serum biomarker.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sepsis patients with 2 of the followings when arrival ER and treated \> 6 hours:

* BT \>38℃ or\<36℃
* HR \>90/min
* RR \>20/min or PaCO2 \< 32 mmHg
* WBC count \>12×109/L or \<4×109/L or immature form \>10％

Exclusion Criteria

* Age \< 18
* Major trauma patients
* Pregnancy
* Willing to do not aggressive treatment

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

National Taiwan University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ER of National Taiwan Univeristy Hospital

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ChiungYuan Hsu, Mph

Role: CONTACT

Phone: 886-2-23123456

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chiung Yuan Hsu, Mph

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200708002R

Identifier Type: -

Identifier Source: org_study_id